GE Healthcare will manufacture single-use consumables for bioprocessing in Weihai, China thanks to a collaboration with healthtech supplier Wego Pharmaceutical.
Bioprocessing
The collaboration aims to decrease product delivery times for biopharmaceutical companies in China, enhance customer support locally and increase access to standard and custom single-use products to help companies bring therapeutics to patients faster.
Single-use products produced by Wego will be manufactured using Fortem, GE Healthcare’s materially advanced platform film, which simplifies the customer validation and approval process by using GE’s range of bioprocessing systems. The first single-use consumables produced by Wego are expected to be available later this month.
Olivier Loeillot, general manager, BioProcess, GE Healthcare Life Sciences, said: “We are excited to play a critical role within the Chinese biopharma industry by ensuring efficient lead times and security of supply, which ultimately helps the local manufacturers to serve patients faster. China continues to lead in the adoption of innovative single-use biomanufacturing solutions, including GE Healthcare’s end-to-end biomanufacturing solutions KUBio and FlexFactory. This highlights that China has a large installed space coupled with a strong biopharma pipeline predominantly based on single-use technologies.”
"It is an honour to have this important strategic collaboration with GE Healthcare that supports our focused vision on technological innovation. GE Healthcare is one of the largest healthcare solution providers in the world and with its strong technical resources and global know-how, we can meet the Chinese customers’ expectations efficiently, helping to localise the development and manufacture of single-use consumables. This will support the development of more affordable, high-quality therapeutics in China,” said Xian-feng Huang, general manager, Wego Pharmaceutical.